cedia logo
Look for
Close this search box.

Design of an efficient enzyme in the activation of the chemotherapeutic drug cyclophosphamide for use in cancer gene therapy.

General Objective: To evaluate the activation efficiency of cyclophosphamide by the improved P450 enzyme using an in vivo reporter system and determine its kinetic characteristics.

Specific objectives:

  • Construct variants of the P450 enzyme by ancestral sequence reconstruction (ASR) and point mutations.
  • Determine the levels of stability and expression in the P450 enzyme variants obtained in objective 1.
  • Quantify the activity of P450 enzyme variants on cyclophosphamide (CPA) using an in vivo reporter system.
  • To evaluate the kinetic properties of the most active P450 enzyme variants obtained from objective 2.

Participating Institutions:

UTE, UCUENCA, USFQ.

Participants:

Project Director Saskya Estefany Carrera Pacheco

  • Johana Janina Zúñiga Miranda
  • Manuel Alfredo Campoverde Cisneros
  • Enrique Eduardo Terán Torres

Awarded budget: $35222,00

Project Status: Completed